| A synthetic aptamer-drug adduct for targeted liver cancer therapy TL Trinh, G Zhu, X Xiao, W Puszyk, K Sefah, Q Wu, W Tan, C Liu PLoS One 10 (11), e0136673, 2015 | 96 | 2015 |
| Integrating the epigenome to identify drivers of hepatocellular carcinoma RA Hlady, A Sathyanarayan, JJ Thompson, D Zhou, Q Wu, K Pham, ... Hepatology 69 (2), 639-652, 2019 | 82 | 2019 |
| Aptamers against cells overexpressing glypican 3 from expanded genetic systems combined with cell engineering and laboratory evolution L Zhang, Z Yang, T Le Trinh, IT Teng, S Wang, KM Bradley, S Hoshika, ... Angewandte Chemie 128 (40), 12560-12563, 2016 | 81 | 2016 |
| A pseudotype baculovirus-mediated vaccine confers protective immunity against lethal challenge with H5N1 avian influenza virus in mice and chickens Q Wu, L Fang, X Wu, B Li, R Luo, Z Yu, M Jin, H Chen, S Xiao Molecular immunology 46 (11-12), 2210-2217, 2009 | 72 | 2009 |
| Swine interferon-induced transmembrane protein, sIFITM3, inhibits foot-and-mouth disease virus infection in vitro and in vivo J Xu, P Qian, Q Wu, S Liu, W Fan, K Zhang, R Wang, H Zhang, H Chen, ... Antiviral research 109, 22-29, 2014 | 38 | 2014 |
| A novel vaccine targeting glypican-3 as a treatment for hepatocellular carcinoma Q Wu, L Pi, T Le Trinh, C Zuo, M Xia, Y Jiao, Z Hou, S Jo, W Puszyk, ... Molecular Therapy 25 (10), 2299-2308, 2017 | 33 | 2017 |
| Rabies-virus-glycoprotein-pseudotyped recombinant baculovirus vaccine confers complete protection against lethal rabies virus challenge in a mouse model Q Wu, F Yu, J Xu, Y Li, H Chen, S Xiao, ZF Fu, L Fang Veterinary microbiology 171 (1-2), 93-101, 2014 | 28 | 2014 |
| Transcatheter arterial chemoembolization combined with interferon-α is safe and effective for patients with hepatocellular carcinoma after curative resection C Zuo, M Xia, J Liu, X Qiu, X Lei, R Xu, H Liu, J Li, Y Li, Q Li, H Xiao, ... Asian Pacific Journal of Cancer Prevention 16 (1), 245-251, 2015 | 27 | 2015 |
| ISG15 as a novel prognostic biomarker for hepatitis B virus-related hepatocellular carcinoma X Qiu, Y Hong, D Yang, M Xia, H Zhu, Q Li, H Xie, Q Wu, C Liu, C Zuo International Journal of Clinical and Experimental Medicine 8 (10), 17140, 2015 | 25 | 2015 |
| Interferon drives HCV scarring of the epigenome and creates targetable vulnerabilities following viral clearance RA Hlady, X Zhao, LY El Khoury, A Luna, K Pham, Q Wu, JH Lee, ... Hepatology 75 (4), 983-996, 2022 | 24 | 2022 |
| Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection C Zuo, M Xia, Q Wu, H Zhu, J Liu, C Liu Oncology Letters 9 (2), 527-534, 2015 | 24 | 2015 |
| Enhanced immunogenicity induced by an alphavirus replicon-based pseudotyped baculovirus vaccine against porcine reproductive and respiratory syndrome virus Q Wu, F Xu, L Fang, J Xu, B Li, Y Jiang, H Chen, S Xiao Journal of virological methods 187 (2), 251-258, 2013 | 18 | 2013 |
| Interferon-α and cyclooxygenase-2 inhibitor cooperatively mediates TRAIL-induced apoptosis in hepatocellular carcinoma C Zuo, X Qiu, N Liu, D Yang, M Xia, J Liu, X Wang, H Zhu, H Xie, H Dan, ... Experimental cell research 333 (2), 316-326, 2015 | 17 | 2015 |
| MiRNA-545 negatively regulates the oncogenic activity of EMS1 in gastric cancer M Ma, J Zhao, Q Wu, K Xiao, S Li, H Zhu, C Liu, H Xie, C Zuo Cancer Medicine, 2018 | 16 | 2018 |
| Enhancement of sorafenib-mediated death of Hepatocellular carcinoma cells by Carnosic acid and Vitamin D2 analog combination Q Wu, X Wang, K Pham, A Luna, GP Studzinski, C Liu The Journal of steroid biochemistry and molecular biology 197, 105524, 2020 | 12 | 2020 |
| Members of the Cyr61/CTGF/NOV protein family: emerging players in hepatic progenitor cell activation and intrahepatic cholangiocarcinoma Q Wu, M Jorgensen, J Song, J Zhou, C Liu, L Pi Gastroenterology Research and Practice 2016 (1), 2313850, 2016 | 10 | 2016 |
| Protective immunity elicited by a pseudotyped baculovirus-mediated bivalent H5N1 influenza vaccine Q Wu, S Xiao, H Fan, Y Li, J Xu, Z Li, W Lu, X Su, W Zou, M Jin, H Chen, ... Antiviral research 92 (3), 493-496, 2011 | 9 | 2011 |
| Interferon drives hepatitis C virus scarring of the epigenome and creates targetable vulnerabilities following viral clearance R Hlady, X Zhao, LY El Khoury, A Luna, K Pham, Q Wu, JH Lee, ... Hepatology 74, 610A-610A, 2021 | 5 | 2021 |
| GPC3-specific chimeric antigen receptor T cell in combination with Sorafenib as a novel therapeutic treatment for hepatocellular carcinoma TL Trinh, Q Wu, LJ Chang, M Ho, C Liu Cancer Research 76 (14_Supplement), 2316-2316, 2016 | 5 | 2016 |
| GPC3-specific chimeric antigen receptor T cell in combination with Sorafenib as a novel therapeutic treatment for hepatocellular carcinoma T Le Trinh, Q Wu, LJ Chang, M Ho, C Liu Cancer Research 76, 2016 | 2 | 2016 |
Weihong Tan 谭蔚泓，Distinguished Pr...Hunan Univ; Shanghai Jiaotong Univ; Univ of Florida; Hangzhou Institute of MedicineVerified email at hnu.edu.cn